Boston Scientific To Pay Up To $425M For Catheter Maker

Law360, New York (November 8, 2012, 1:54 PM EST) -- Boston Scientific Corp. will purchase private equity-backed medical device maker Vessix Vascular Inc. in a deal worth up to $425 million, giving it control over Vessix’s novel V2 blood pressure-control catheter system, the companies announced Thursday.

BSC will pay $125 million upfront for Laguna Hills, Calif.-based medical device maker, taking control from a suite of private equity and venture capital owners, including NeoMed Management AS, Edmond de Rothschild Investment Partners, Fjord Invest Management AS, OrbiMed Advisors LLC and Christopher Weil & Co. The agreement also calls...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.